Nigeria News
COVID-19 Drug: WHO Halts Clinical Trials Of Hydroxychloroquine Once Again
The clinical trials of hydroxychloroquine as a potential treatment for coronavirus (COVID-19) has finally been stopped by the world health organisation with the view that the drug has no meaning full impact On the virus
World’s main health regulatory organisation has finally halted the clinical trials of hydroxychloroquine.
Naija News Understands that hydroxychloroquine which is perceived as a potential treatment for coronavirus (COVID-19) was stopped with the view that the drug has no meaning full impact on the virus.
World Health Organization (WHO) revealed that several studies have indicated that Hydroxychloroquine (an anti-malaria drug) has no impact whatsoever on the virus, and does not result in the reduction of mortality of hospitalised COVID-19 patients.
This is coming days after U.S Food and Drug Administration (FDA) revoked the emergency authorisation for Hydroxychloroquine to treat hospitalized COVID-19 patients, amidst several pieces of evidence that it could cause serious side-effects, and that it does not work.
The WHO made this known via the tweet below:
This evidence does not apply to the use of hydroxychloroquine for preventing #COVID19 infections or treating non-hospitalized patients, two areas where we still need more evidence on the drug's effectiveness against the #coronavirus.
— World Health Organization (WHO) (@WHO) June 18, 2020
